Sei Investments Co. lessened its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,017,357 shares of the conglomerate’s stock after selling 24,243 shares during the period. Sei Investments Co. owned approximately 0.14% of Danaher worth $233,541,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Geo Capital Gestora de Recursos Ltd increased its holdings in Danaher by 5,626.7% during the 4th quarter. Geo Capital Gestora de Recursos Ltd now owns 4,295 shares of the conglomerate’s stock worth $986,000 after acquiring an additional 4,220 shares during the period. Plancorp LLC grew its stake in Danaher by 9.0% in the 4th quarter. Plancorp LLC now owns 4,046 shares of the conglomerate’s stock worth $929,000 after buying an additional 335 shares in the last quarter. Mizuho Securities USA LLC grew its stake in Danaher by 46.2% in the 4th quarter. Mizuho Securities USA LLC now owns 60,925 shares of the conglomerate’s stock worth $13,985,000 after buying an additional 19,245 shares in the last quarter. Quantbot Technologies LP purchased a new position in Danaher in the 4th quarter worth approximately $2,849,000. Finally, Millstone Evans Group LLC purchased a new position in Danaher in the 4th quarter worth approximately $101,000. Institutional investors own 79.05% of the company’s stock.
Insider Transactions at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 10.90% of the company’s stock.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Danaher
Danaher Stock Up 0.7 %
Shares of NYSE DHR opened at $211.63 on Friday. The firm has a fifty day simple moving average of $217.46 and a two-hundred day simple moving average of $238.86. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $151.26 billion, a PE ratio of 40.08, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 earnings per share. Equities analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s dividend payout ratio (DPR) is currently 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What Are the U.K. Market Holidays? How to Invest and Trade
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 5 Top Rated Dividend Stocks to Consider
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- How to Buy Cheap Stocks Step by Step
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.